Meta & Google Ads · Peptide marketing

Compliant paid ads that actually stay live.

Most peptide ad accounts don’t get banned for being peptide accounts — they get banned for how they’re run. We build Meta and Google campaigns on strict research-use-only positioning, so the account survives review, keeps spending, and scales. No cloaking, no human-use claims, no burner accounts.

Get an ads audit See the numbers
Live Accounts kept in good standing
X.X× Return on ad spend (blended)
£XX Cost per acquisition
XX% Approval rate on submitted ads

The difference

Why our ad accounts sustain.

Google and Meta classify many peptides under healthcare and pharmaceutical policy. The category is genuinely ambiguous: research-grade peptides sold for laboratory use aren’t consumer drugs, but the moment an ad or landing page implies human consumption, it collides with policy. That single line — research use vs human use — is where almost every banned account crosses over. We run the entire funnel on the right side of it.

Research-use-only copy

Ad creative and copy positioned strictly for laboratory and research use. No dosage, no health outcomes, no before/after, no human-consumption framing — the claims that trigger disapprovals never appear.

Clean, consistent landing pages

The page the ad points to matches the ad exactly and holds the same RUO line. What the reviewer clicks is what the customer sees. No cloaking, no doorway pages, no bait-and-switch — the practices that get accounts permanently banned.

Correct account setup

Proper business verification, accurate categorisation, and policy-aligned structure from day one. Legitimate accounts built to pass review, not disposable accounts built to be replaced.

Continuous policy monitoring

Platform policies shift constantly. We track changes, pre-empt disapprovals, and keep creative within the current line — so a policy update is a heads-up, not a shutdown.

Platforms

Google and Meta, run properly.

Google Ads

Search and Shopping structured around research-use intent, with landing pages and feed data that hold the compliance line. We capture buyers already searching — the highest-intent traffic in peptide marketing — without tripping pharmaceutical policy.

Meta Ads

Prospecting and retargeting with creative built to pass review and a pixel/CAPI setup that measures what actually converts. Audiences and messaging tuned for a research audience, not a consumer-health one.

Paid ads work hardest alongside the channels you own. We pair every ads engagement with email capture and CRO, so traffic you pay for becomes a list and revenue you keep — and if an account ever is disrupted, the business doesn’t stop with it.

Honest answers

The questions worth asking.

Can you guarantee my account won’t get banned?
No one honest can. Platform policies change and reviews involve judgement. What we do is remove the reasons accounts actually get banned — non-compliant claims, mismatched landing pages, poor account setup — and monitor continuously so problems are caught early. We also make sure you’re never dependent on ads alone, by building owned channels in parallel.
Isn’t advertising peptides against policy?
Advertising them for human consumption is. Research-grade peptides for laboratory use occupy a narrower, permitted lane when the copy and landing page stay strictly within research-use framing and make no health or dosage claims. Staying inside that lane is the entire discipline — and the reason our accounts sustain where workaround accounts don’t.
What about UK rules, not just platform rules?
Advertising is governed by the FTC and FDA in the US and by the ASA/CAP Code and MHRA in the UK, and some peptides may fall under rules on unapproved or unlicensed medicines in either market. Our copy holds research-use-only positioning on all those grounds. We’re marketers, not lawyers — for products where regulatory status is unclear, you should have qualified counsel review before scaling spend.
Will you rotate accounts if one goes down?
No. Account rotation, re-warming and evasion are exactly the practices that mark an advertiser as high-risk and lead to permanent bans. We build accounts to stay up. If a disapproval happens, we fix the underlying cause and appeal properly.

Next step

One call. One audit. A plan you keep either way.

Book a 30-min call